Literature DB >> 24047969

The effect of churn on "community viral load" in a well-defined regional population.

Hartmut B Krentz1, M John Gill.   

Abstract

BACKGROUND: The concept of community viral load (CVL) was introduced to quantify the pool of transmissible HIV within a community and to monitor the potential impact of highly active antiretroviral therapy (HAART) on reducing new infections. The implications of churn (patient movement in/out of care in a community) on CVL have not been studied.
METHODS: The annual CVL was determined in the entire geographic HIV population receiving care in southern Alberta from 2001 to 2010; the CVL for specific subpopulations was analyzed for 2009. CVL was determined for patients under continuous care, newly diagnosed, new to the region, moved away, returned, and lost to follow-up (LTFU). Viral loads (VLs) <50 or <200 copies per milliliter were deemed undetectable and suppressed, respectively. The mean VL per patient and total VL were used to determine CVL.
RESULTS: From 2001 to 2010, the HAART uptake for all patients increased from 62% to 81%, undetectability from 32% to 66%, and suppression from 49% to 72%. The annual total CVL however did not vary significantly after 2003. Incidence rates for new locally diagnosed infections increased from 4.4 to 5.8/100,000 per year. In 2009, newly diagnosed HIV patients (6.6%) contributed 37.5% to the CVL, whereas patients transferring in/out of the region or lost to follow-up contributed 33% to the CVL. Patients in continuous care (79% of all patients) contributed 29.5% to the total CVL.
CONCLUSIONS: Increasing HAART coverage did not reduce the CVL or reduce new HIV diagnoses in our population. The effect of churn significantly limited CVL use as a measure for evaluating the impact of HAART in reducing HIV transmissions in our population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24047969     DOI: 10.1097/QAI.0b013e31829cef18

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS.

Authors:  Jonathan Colasanti; Natalie Stahl; Eugene W Farber; Carlos Del Rio; Wendy S Armstrong
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

2.  Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.

Authors:  Lars I Gjærde; Leah Shepherd; Elzbieta Jablonowska; Adriano Lazzarin; Mathieu Rougemont; Katharine Darling; Manuel Battegay; Dominique Braun; Valerie Martel-Laferriere; Jens D Lundgren; Jürgen K Rockstroh; John Gill; Andri Rauch; Amanda Mocroft; Marina B Klein; Lars Peters
Journal:  Clin Infect Dis       Date:  2016-06-15       Impact factor: 9.079

3.  Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.

Authors:  Ashly E Jordan; Charles M Cleland; Bruce R Schackman; Katarzyna Wyka; David C Perlman; Denis Nash
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

4.  Validation of Retention in HIV Care Status Using the New York City HIV Surveillance Registry and Clinical Care Data From a Large HIV Care Center.

Authors:  Rituparna Pati; Rebekkah S Robbins; Sarah L Braunstein
Journal:  J Public Health Manag Pract       Date:  2017 Nov/Dec

5.  The Impact of Churn on HIV Outcomes in a Southern United States Clinical Cohort.

Authors:  Srinivasa Nithin Gopalsamy; N Sarita Shah; Vincent C Marconi; Wendy S Armstrong; Carlos Del Rio; Eugene Pennisi; Pascale Wortley; Jonathan A Colasanti
Journal:  Open Forum Infect Dis       Date:  2022-07-08       Impact factor: 4.423

6.  Reduction in HIV community viral loads following the implementation of a "Treatment as Prevention" strategy over 2 years at a population-level among men who have sex with men in Hangzhou, China.

Authors:  Lin He; Jiezhe Yang; Qiaoqin Ma; Jiafeng Zhang; Yun Xu; Yan Xia; Wanjun Chen; Hui Wang; Jinlei Zheng; Jun Jiang; Yan Luo; Ke Xu; Xingliang Zhang; Shichang Xia; Xiaohong Pan
Journal:  BMC Infect Dis       Date:  2018-02-01       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.